Skip to main content
Caplight Logo









4M Therapeutics

4M Therapeutics

Private
New JerseyHealthcare & Life Scienceshttps://www.4mtx.net/

Last Round

Seed

Aug 28, 2025

Total Funding Raised

$4.12M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

4M Therapeutics is a biotechnology company that develops targeted therapies for neuropsychiatric and neurodegenerative conditions using a proprietary human brain cell platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Mental Health, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryinduced pluripotent stem cellsiPSCCNS therapeuticsneuropsychiatric diseaseneurodegenerative diseasesmall molecule therapypeptide therapyGSK3β inhibitorCDK5 inhibitorprecision medicinebiotech startupdrug pipelinepreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

4M Therapeutics Comparables

Compare 4M Therapeutics with similar companies based on industry and business-model similarity.

4M Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cogentis Therapeutics
89%
AMO Pharma
80%
Autobahn Therapeutics
76%

4M Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 28, 2025
GrantNov 12, 2024
Pre SeedAug 28, 2023

Key People

Founding team and executive leadership

Pablo Lapuerta

Chief Executive Officer

Executive Team

4M Therapeutics Investors

Notable investors and investment history

4M Therapeutics investors
InvestorRounds
LvlUp VenturesPre Seed
Harvard Alumni EntrepreneursPre Seed
SynGAP Research FundGrant, Pre Seed
Endless Frontier LabsPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 36% MoM.

  • Jan 21, 2026

    Monthly visitors grew 126% MoM, reaching 2.9K.

4M Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

4M Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 4M Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Jersey
Employee Range6
Year FoundedN/A
Last FundingAug 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?